195 related articles for article (PubMed ID: 17612852)
21. Clinical experience with dual action antidepressants in different chronic pain syndromes.
Briley M
Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S21-5. PubMed ID: 15378667
[TBL] [Abstract][Full Text] [Related]
22. Escitalopram for the treatment of major depression and anxiety disorders.
Höschl C; Svestka J
Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657
[TBL] [Abstract][Full Text] [Related]
23. The human cost of not achieving full remission in depression.
McIntyre RS; O'Donovan C
Can J Psychiatry; 2004 Mar; 49(3 Suppl 1):10S-16S. PubMed ID: 15147032
[TBL] [Abstract][Full Text] [Related]
24. Reboxetine: a norepinephrine selective reuptake pump inhibitor.
Preskorn SH
J Psychiatr Pract; 2004 Jan; 10(1):57-63. PubMed ID: 15334987
[No Abstract] [Full Text] [Related]
25. Efficacy and safety of duloxetine in fibromyalgia.
Ursini F; Pipicelli G; Grembiale RD
Clin Ter; 2010; 161(4):391-5. PubMed ID: 20931165
[TBL] [Abstract][Full Text] [Related]
26. The efficacy, tolerability, and safety of contemporary antidepressants.
Papakostas GI
J Clin Psychiatry; 2010; 71 Suppl E1():e03. PubMed ID: 20371030
[TBL] [Abstract][Full Text] [Related]
27. Antidepressant agents for the treatment of chronic pain and depression.
Jann MW; Slade JH
Pharmacotherapy; 2007 Nov; 27(11):1571-87. PubMed ID: 17963465
[TBL] [Abstract][Full Text] [Related]
28. The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.
Bymaster FP; Lee TC; Knadler MP; Detke MJ; Iyengar S
Curr Pharm Des; 2005; 11(12):1475-93. PubMed ID: 15892657
[TBL] [Abstract][Full Text] [Related]
29. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
Smits KM; Smits LJ; Schouten JS; Peeters FP; Prins MH
Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
[TBL] [Abstract][Full Text] [Related]
30. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
[TBL] [Abstract][Full Text] [Related]
31. Clinician perspective on achieving and maintaining remission in depression.
Kelsey JE
J Clin Psychiatry; 2001; 62 Suppl 26():16-21. PubMed ID: 11775088
[TBL] [Abstract][Full Text] [Related]
32. Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods.
Girardi P; Pompili M; Innamorati M; Mancini M; Serafini G; Mazzarini L; Del Casale A; Tatarelli R; Baldessarini RJ
Hum Psychopharmacol; 2009 Apr; 24(3):177-90. PubMed ID: 19229839
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients.
Dolder C; Nelson M; Stump A
Drugs Aging; 2010 Aug; 27(8):625-40. PubMed ID: 20658791
[TBL] [Abstract][Full Text] [Related]
34. Duloxetine Eli Lilly.
Anttila S; Leinonen E
Curr Opin Investig Drugs; 2002 Aug; 3(8):1217-21. PubMed ID: 12211418
[TBL] [Abstract][Full Text] [Related]
35. A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression.
Perahia DG; Quail D; Gandhi P; Walker DJ; Peveler RC
J Affect Disord; 2008 May; 108(1-2):33-41. PubMed ID: 17905442
[TBL] [Abstract][Full Text] [Related]
36. Major depressive disorder: remission of associated symptoms.
Trivedi MH
J Clin Psychiatry; 2006; 67 Suppl 6():27-32. PubMed ID: 16848674
[TBL] [Abstract][Full Text] [Related]
37. Achieving remission and managing relapse in depression.
Thase ME
J Clin Psychiatry; 2003; 64 Suppl 18():3-7. PubMed ID: 14700448
[TBL] [Abstract][Full Text] [Related]
38. Visual hallucinations during duloxetine treatment in a patient with major depressive disorder.
Tomita T; Yasui-Furukori N; Kaneko S
Clin Neuropharmacol; 2013; 36(5):175-6. PubMed ID: 24045610
[TBL] [Abstract][Full Text] [Related]
39. Duloxetine: a review of its use in the treatment of major depressive disorder.
Frampton JE; Plosker GL
CNS Drugs; 2007; 21(7):581-609. PubMed ID: 17579500
[TBL] [Abstract][Full Text] [Related]
40. Special issues in the management of depression in older patients.
Rabheru K
Can J Psychiatry; 2004 Mar; 49(3 Suppl 1):41S-50S. PubMed ID: 15147035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]